Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 3
1995 1
1996 3
1997 2
1998 2
1999 2
2000 1
2001 4
2002 5
2003 2
2004 3
2005 4
2006 9
2007 14
2008 27
2009 35
2010 38
2011 32
2012 33
2013 36
2014 47
2015 37
2016 42
2017 41
2018 41
2019 29
2020 33
2021 34
2022 40
2023 37
2024 20

Text availability

Article attribute

Article type

Publication date

Search Results

570 results

Results by year

Filters applied: . Clear all
Page 1
Desvenlafaxine.
[No authors listed] [No authors listed] 2024 Jan 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2024 Jan 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000652 Free Books & Documents. Review.
Modest doses of desvenlafaxine are excreted into breastmilk, but serum drug levels of breastfed infants are less than 10% of simultaneous maternal levels. ...With the related drug venlafaxine, newborn infants of mothers who took the drug during pregnancy sometimes experien …
Modest doses of desvenlafaxine are excreted into breastmilk, but serum drug levels of breastfed infants are less than 10% of simultan …
Venlafaxine, Desvenlafaxine.
[No authors listed] [No authors listed] 2020 Mar 6. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2020 Mar 6. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31644106 Free Books & Documents. Review.
Desvenlafaxine.
Naseeruddin R, Rosani A, Marwaha R. Naseeruddin R, et al. 2023 Jul 10. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Jul 10. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 30521250 Free Books & Documents.
Desvenlafaxine is an antidepressant that is an FDA-approved drug to treat major depressive disorder in adults. ...This activity will highlight the mechanism of action, adverse event profile, off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, and releva …
Desvenlafaxine is an antidepressant that is an FDA-approved drug to treat major depressive disorder in adults. ...This activity will …
Desvenlafaxine in the treatment of major depression: an updated overview.
Norman TR, Olver JS. Norman TR, et al. Expert Opin Pharmacother. 2021 Jun;22(9):1087-1097. doi: 10.1080/14656566.2021.1900826. Epub 2021 Mar 23. Expert Opin Pharmacother. 2021. PMID: 33706624 Review.
Hepatic impairment does not significantly alter dose requirements, whereas severe renal disease requires some adjustments of dose. Desvenlafaxine maybe suitable in patients with comorbid physical illnesses. Desvenlafaxine can be a first line consideration for the tr …
Hepatic impairment does not significantly alter dose requirements, whereas severe renal disease requires some adjustments of dose. Desven …
Head-To-Head Comparison of Vortioxetine Versus Desvenlafaxine in Patients With Major Depressive Disorder With Partial Response to SSRI Therapy: Results of the VIVRE Study.
McIntyre RS, Florea I, Pedersen MM, Christensen MC. McIntyre RS, et al. J Clin Psychiatry. 2023 May 22;84(4):23m14780. doi: 10.4088/JCP.23m14780. J Clin Psychiatry. 2023. PMID: 37227402 Clinical Trial.
Objective: To compare the efficacy of vortioxetine and the serotonin-norepinephrine reuptake inhibitor (SNRI) desvenlafaxine in patients with major depressive disorder (MDD) experiencing partial response to initial treatment with a selective serotonin reuptake inhibitor (S …
Objective: To compare the efficacy of vortioxetine and the serotonin-norepinephrine reuptake inhibitor (SNRI) desvenlafaxine in patie …
Desvenlafaxine extended release.
Yang LP, Plosker GL. Yang LP, et al. CNS Drugs. 2008;22(12):1061-9. doi: 10.2165/0023210-200822120-00008. CNS Drugs. 2008. PMID: 18998743 Review. No abstract available.
Efficacy and tolerability of desvenlafaxine in the real-world treatment of patients with major depression: a narrative review and an expert opinion paper.
Sampogna G, Caraci F, Carmassi C, Dell'Osso B, Ferrari S, Martinotti G, Sani G, Serafini G, Signorelli MS, Fiorillo A. Sampogna G, et al. Expert Opin Pharmacother. 2023 Sep-Dec;24(14):1511-1525. doi: 10.1080/14656566.2023.2237410. Epub 2023 Jul 23. Expert Opin Pharmacother. 2023. PMID: 37450377 Review.
A narrative review on efficacy, tolerability and use of desvenlafaxine in clinical practice was carried out. The keywords: 'major depression', 'depression,' 'desvenlafaxine,' 'efficacy,' 'clinical efficacy,' 'side effects', 'tolerability,' 'elderly patients', 'consu …
A narrative review on efficacy, tolerability and use of desvenlafaxine in clinical practice was carried out. The keywords: 'major dep …
Desvenlafaxine.
Andrade C. Andrade C. Indian J Psychiatry. 2009 Oct-Dec;51(4):320-3. doi: 10.4103/0019-5545.58303. Indian J Psychiatry. 2009. PMID: 20048462 Free PMC article. No abstract available.
Desvenlafaxine: another "me too" drug?
Sopko MA Jr, Ehret MJ, Grgas M. Sopko MA Jr, et al. Ann Pharmacother. 2008 Oct;42(10):1439-46. doi: 10.1345/aph.1K563. Epub 2008 Aug 12. Ann Pharmacother. 2008. PMID: 18698015 Review.
OBJECTIVE: To compare desvenlafaxine with its parent drug, venlafaxine, to determine the usefulness of this new medication. ...DATA SYNTHESIS: Desvenlafaxine is a serotonin-norepinephrine reuptake inhibitor and is the active metabolite of the antidepressant venlafax …
OBJECTIVE: To compare desvenlafaxine with its parent drug, venlafaxine, to determine the usefulness of this new medication. ...DATA S …
Desvenlafaxine: a new antidepressant or just another one?
Pae CU. Pae CU. Expert Opin Pharmacother. 2009 Apr;10(5):875-87. doi: 10.1517/14656560902828351. Expert Opin Pharmacother. 2009. PMID: 19351235 Review.
Desvenlafaxine (DVS) is a serotonin-norepinephrine reuptake inhibitor (SNRI) with a different pharmacokinetic and pharmacodynamic profile to venlafaxine. ...
Desvenlafaxine (DVS) is a serotonin-norepinephrine reuptake inhibitor (SNRI) with a different pharmacokinetic and pharmacodynamic pro …
570 results

Searches related to "desvenlafaxine"